Clinical Trial Update: Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis? [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether omega-3 fatty acid supplementation affects cardiomyocyte membranes in patients with coronary atherosclerosis; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Atherosclerosis

Drugs mentioned

• Omega-3 fatty acid supplementation (Omega-3 fatty acids)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Coronary Atherosclerosis | Phase 3 | Status: UNKNOWN